AI in healthcare has mostly focused on administrative tasks like scheduling and billing, but a new wave of innovation is targeting something far more transformative: detecting disease before symptoms appear by analyzing the body's invisible signals. Nearly half of all digital health investment now flows toward AI, yet most applications remain in the operational plumbing of healthcare rather than improving actual patient outcomes. That's beginning to shift, with companies and academic centers developing AI systems that catch early warning signs in everything from eye vasculature to fetal brain activity to vocal patterns.

What Signals Is AI Learning to Read?

The human body constantly broadcasts information through subtle physiological patterns, but we've lacked the sensory tools and analytical capacity to detect them. AI is changing that equation. Researchers at Mayo Clinic recently published findings showing an AI model that identified pancreatic cancer on routine abdominal CT scans up to three years before clinical diagnosis appeared. This represents a fundamental shift from reactive medicine, where doctors treat disease after it's symptomatic, to anticipatory medicine, where AI catches killers before they do damage.

The emerging category of AI "signal catchers" works by making invisible physiological signals actionable through non-invasive or minimally-invasive methods. These breakthroughs span multiple body systems and detection approaches:

• Eye-Based Biomarkers: Companies like Optain are applying AI to oculomics, using the blood vessel patterns in the eye to predict cardiovascular and eye disease before clinical symptoms emerge.
• Cognitive and Emotional States: Harmoneyes has developed an AI-powered eye-tracking platform that identifies and predicts a person's cognitive, emotional, and physical state based on eye movement patterns.
• Fetal Distress Detection: VitalTrace is pioneering continuous lactate monitoring to accurately detect fetal distress, while Wavelet has launched the first non-invasive fetal EEG monitoring platform to reduce unnecessary cesarean sections and brain injuries.
• Voice-Based Disease Detection: Canary Speech and Sonde Health are developing vocal biomarkers to support early detection of cognitive and respiratory diseases through speech analysis.

Why Does Early Detection Matter So Much?

The stakes are staggering. A healthy baby born in the United States today has the biological potential to live 120 years, yet life expectancy sits closer to 80 years. That means Americans are forfeiting roughly one-third of their potential lifespan from day one. Globally, life expectancy gains have slowed dramatically; over the past two decades, the world added roughly five years to life expectancy, but removing the effect of declining infant mortality drops that figure to three years, or about 1.5 years per decade. Progress exists, but it's slower than longevity improvements achieved throughout most of the last century.

Late-stage diagnosis drives much of this gap. When diseases like cancer, diabetes, kidney disease, and hypertension are caught at stage 3 or 4, the impact on both lifespan and healthspan becomes catastrophic. Even maternity care, despite extraordinary innovation and spending, shows worsening outcomes at scale; maternal mortality in the U.S. is higher than it was 20 years ago, with severe complications and cesarean sections both increasing.

How Can Healthcare Leaders Implement Signal-Detection AI?

The transition from administrative AI to outcome-focused AI requires strategic shifts across the healthcare ecosystem:

• Invest in Biomarker Research: Partner with academic medical centers and early-stage companies developing AI models that identify and amplify existing vital signs and biomarkers, or create entirely new biomarkers that weren't previously observable or actionable.
• Integrate Non-Invasive Monitoring: Deploy AI-powered monitoring systems across the care spectrum, from predisposition and prediction through diagnosis, prognosis, treatment selection, and ongoing monitoring, using minimally-invasive or non-invasive methods.
• Build Collaboration Networks: Establish partnerships between health systems, academic institutions, venture investors, and entrepreneurs to accelerate the development and validation of signal-catching technologies before they reach clinical scale.
• Focus on Clinical Endpoints: Measure success not by workflow improvements or cost savings, but by changes in actual health outcomes, lifespan, and the gap between years lived in full health versus years lived with disease.

Is This Actually a Healthcare Revolution Yet?

The narrative around AI in healthcare often invokes revolutionary language, but the evidence tells a more measured story. AI is currently working mostly in the operational infrastructure of healthcare: better workflows, reduced administrative burden, improved decision support. The effect on clinical endpoints remains nascent and unevenly distributed. This is evolution in healthcare delivery, not yet a revolution in health itself, though the field sits at an inflection point.

What distinguishes the emerging signal-catching category is its focus on the fundamental problem: we live an average of a dozen years in less than full health, and the ratio of healthspan (measured by healthy life expectancy) to total lifespan hasn't budged. Making marginal improvements to existing systems won't close that gap. Only by detecting disease years earlier, before it progresses to late stages, can AI meaningfully expand both lifespan and healthspan.

"Using AI to understand the body's signals will increase our years and close the gap between the good ones and bad ones," noted Murray Brozinsky, Partner at Aegis Ventures.

Murray Brozinsky, Partner at Aegis Ventures

The historical pattern is instructive. Medical breakthroughs have always come from closing the gap between the signals our bodies send and our ability to detect and interpret them. The stethoscope revealed signals carried through sound. X-rays uncovered signals embedded in bone. Ultrasound captured signals in soft tissue using high-frequency sound waves. AI is poised to do something similar by helping detect, improve, and interpret signals that have always been there but were too subtle, complex, or multidimensional for humans to recognize and use.

As investment and collaboration activity heat up around these signal-detection technologies, the question is no longer whether AI can improve healthcare operations. The question is whether it can finally deliver on the promise of anticipatory medicine, catching disease before it steals decades from our lives.